Tickers

1. Composite Trajectory Verdict

For a BDC, the income statement (net investment income and dividend coverage) and balance sheet (NAV per share, asset coverage, portfolio quality) carry the most weight because they directly reflect earnings power and capital preservation; cash flow is secondary given that operating cash flows include portfolio purchases and sales.

Composite Trajectory: Mixed

Total investment income grew 9.9% to $255.6M and the portfolio expanded 36.6% to $2.46B fair value, driven by the CSL III Merger and Credit Fund II Purchase (10-K 2025-12-31, Consolidated Results of Operations; Portfolio Overview). However, net investment income per share fell 26% to $1.48 from $2.00, dividends per share declined to $1.65 from $1.87, and NAV per share dropped to $16.26 from $16.80 (10-K 2025-12-31, MD&A). Leverage increased (debt-to-equity 1.32x vs 1.20x), asset coverage fell to 175.6% from 183.2%, non-accruals doubled to 1.2% of fair value, and the portfolio yield compressed 160 bps to 10.1% (10-K 2025-12-31, Portfolio Financing; Portfolio Credit; Investment Income). The per-share deterioration offsets the scale improvement.

2. Red Flags

• Dividend coverage below 100%: Net investment income per share of $1.48 vs dividends declared of $1.65 in 2025, compared to $2.00 NII vs $1.87 dividends in 2024 (10-K 2025-12-31, MD&A).
• Operating cash flow swung negative: Cash from operations was -$204.6M in 2025 vs +$104.3M in 2024, driven by $1.33B investment purchases against $997.5M sales/repayments (10-K 2025-12-31, Cash Flows).
• Non-accrual investments doubled: Fair value of non-accrual investments rose to $30.5M (1.2% of portfolio) from $10.4M (0.6%) (10-K 2025-12-31, Portfolio Credit).
• Asset coverage approaching minimum: Ratio declined to 175.6% from 183.2%, nearing the 150% regulatory floor (10-K 2025-12-31, Asset Coverage).
• Portfolio yield compression: Weighted average yield on debt and income-producing assets fell to 10.1% from 11.7% at amortized cost (10-K 2025-12-31, Investment Income).
• Widening realized losses: Net realized loss on investments increased to $58.1M from $38.3M (10-K 2025-12-31, Consolidated Results of Operations).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Deteriorating

Net investment income declined 4.3% to $100.7M from $105.3M, but per-share NII fell 26% to $1.48 from $2.00 due to a 33% increase in weighted-average shares outstanding (67.7M vs 50.8M) following merger-related equity issuance (10-K 2025-12-31, Net Investment Income). Total investment income rose 9.9% to $255.6M, yet expenses surged 21.6% to $154.8M, led by interest expense (+28.6% to $88.1M) and base management fees (+28.7% to $34.6M) (10-K 2025-12-31, Consolidated Results of Operations). Net realized losses widened to $58.1M from $38.3M, partially offset by higher unrealized appreciation ($39.2M vs $18.3M). Basic EPS dropped to $1.02 from $1.68, and dividends per share decreased to $1.65 from $1.87 (10-K 2025-12-31, MD&A).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Deteriorating

Cash provided by operating activities turned negative at -$204.6M in 2025 from +$104.3M in 2024, primarily due to $1.33B of investment purchases exceeding $997.5M of sales and repayments (10-K 2025-12-31, Cash Flows). Cash from financing activities was +$224.5M vs -$108.1M, reflecting $300M of 2031 Notes issuance, $134.6M net credit facility borrowings, and $85M redemption of 2028 Notes (10-K 2025-12-31, Cash Flows; Liquidity and Capital Activity). The net cash increase was only $19.9M after a $3.9M decrease in 2024. The shift to negative operating cash flow reflects aggressive portfolio deployment rather than a fundamental cash burn, but it marks a clear deterioration in the cash flow profile.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

Total investments at fair value grew to $2.46B from $1.80B, but NAV per share fell 3.2% to $16.26 from $16.80 (10-K 2025-12-31, Portfolio Overview; MD&A). Total debt outstanding rose 57.8% to $1.54B from $978.4M, pushing the statutory debt-to-equity ratio to 1.32x from 1.20x and reducing asset coverage to 175.6% from 183.2% (10-K 2025-12-31, Portfolio Financing; Asset Coverage). Non-accrual investments doubled to 1.2% of fair value ($30.5M) from 0.6% ($10.4M), and the weighted average portfolio yield compressed to 10.1% from 11.7% (10-K 2025-12-31, Portfolio Credit; Investment Income). Total liquidity declined to $472.8M from $565.7M (10-K 2025-12-31, Sources of Liquidity).

6. Data Gaps

• Quarterly GAAP financial statements for 2026 (10-Qs for 2026-06-30, 2026-03-31) and 2025 (10-Qs for 2025-09-30, 2025-06-30) were listed as provided but their content was not included in the filing text, preventing quarterly trend analysis and YoY quarterly comparisons.
• Full cash flow statement line items for 2024 (beyond the net operating/financing totals shown in the 10-K) to assess working capital components.
• Annual data for 2023 (referenced in the 10-K but not provided) to establish a three-year trend for key metrics.